Back to discover
Disease
Cholangitis, Sclerosing
Active therapeutic pipelineEmerging research
1
Publications
6
Clinical trials
2017
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Cholangiocarcinoma: Current Knowledge and New Developments.
Research2017-01-01Gut and liver
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
6
1
0
3
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Leading journals1
- Gut and liver1
Leading researchers1
- Blechacz B1
Affiliations (unnormalised)1
- The University of Texas MD Anderson Cancer Center1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.